The University of Chicago Header Logo

Connection

S. Margaret Paik to Deoxycytidine

Back to Details
This is a "connection" page, showing publications S. Margaret Paik has written about Deoxycytidine.
S. Margaret Paik
Connection Strength
0.027
Deoxycytidine
  1. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Lancet Oncol. 2015 Sep; 16(9):1037-1048.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.